| Literature DB >> 28246023 |
Clarissa Perdigão Mello1, Danya Bandeira Lima1, Ramon Róseo Paula Pessoa Bezerra de Menezes2, Izabel Cristina Justino Bandeira1, Louise Donadello Tessarolo1, Tiago Lima Sampaio2, Claudio Borges Falcão1, Gandhi Rádis-Baptista3, Alice Maria Costa Martins4.
Abstract
Antimicrobial peptides (AMPs) are potential alternatives to conventional antibiotics, as they have a fast mode of action, a low likelihood of resistance development and can act in conjunction with existing drug regimens. We report in this study the effects of batroxicidin (BatxC), a cathelicidin-related AMP from Bothrops atrox venom gland, over Trypanosoma cruzi, a protozoan that causes Chagas' disease. BatxC inhibited all T. cruzi (Y strain: benznidazole-resistant) developmental forms, with selectivity index of 315. Later, separate flow cytometry assays showed T. cruzi cell labeling by 7-aminoactinomycin D, the increase in reactive oxygen species and the loss of mitochondrial membrane potential when the parasite was treated with BatxC, which are indication of necrosis. T. cruzi cell death pathway by a necrotic mechanism was finally confirmed by scanning electron microscopy which observed loss of cell membrane integrity. In conclusion, BatxC was able to inhibit T. cruzi, with high selectivity index, by inducing necrosis.Entities:
Keywords: Antimicrobial peptide; Batroxicidin; Cathelicidin; Chagas' disease; Necrosis; Trypanosoma cruzi
Mesh:
Substances:
Year: 2017 PMID: 28246023 DOI: 10.1016/j.toxicon.2017.02.031
Source DB: PubMed Journal: Toxicon ISSN: 0041-0101 Impact factor: 3.033